[1] 郭欣,吴志宇,陈春悠.临床颈淋巴结阴性甲状腺乳头状癌不同手术方式的疗效比较[J].中国肿瘤临床,2016,43(9):366-370. [2] Wenig BM, Thompson LR, Adair CF, et al. Thyroid papillary carcinoma of columnar cell type[J].Cancer,2015, 82(4): 740-753. [3] Ono M, Ohkouchi S, Kanehira M, et al. Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1[J].Mol Ther,2015, 23(3): 549-560. [4] 丁晶晶,刘欣艳.STC-1在宫颈癌中的表达及其在预后判断中的价值[J].临床与病理杂志,2017,37(9):1850-1854. [5] Zandberga E, Zayakin P, Abols A, et al. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells[J].Cancer Biol Ther,2017, 18(8): 596-605. [6] Rezapour S, Bahrami T, Hashemzadeh SA, et al. STC1 and NF-kappa B p65 (Rel A) is constitutively activated in colorectal cancer[J].Clin Lab,2016, 62(3): 463-469. [7] 陈萍,金向明,刘新兰,等.KIF14过表达与胃肠癌患者预后的关系[J].中国全科医学,2016,19(8):931-935. [8] Sugino K, Jr KI, Ozaki O, et al. Papillary microcarcinoma of the thyroid[J].J Endocrinol Invest,2016, 21(7): 445-448. [9] Xue N, Xu Y, Huang P, et al. Shear wave elastography diagnosis of the diffuse sclerosing variant of papillary thyroid carcinoma:A case report[J].Mol Clin Oncol,2016, 5(2): 333. [10] Jepsen MR, Kloverpris S, Botkjaer JA, et al. The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and-2 during human ovarian follicle development[J].Hum Reprod,2016, 31(4): 866-874. [11] 褚少军,张靖.斯钙素1与肿瘤[J].国际消化病杂志,2015,35(1):59-61. [12] Hayase S, Sasaki Y, Matsubara T, et al. Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells[J].Thyroid,2015, 25(4): 425-436. [13] 杨舒雯,马奔,周力,等.斯钙素的生物学特征及其与人体肿瘤关系研究进展[J].中国癌症杂志,2016,26(10):875-880. [14] 苏世强,庞书舰,王少刚.斯钙素在肾细胞癌发病机制中的作用研究进展[J].医学研究生学报,2016(2):210-213. [15] 张亚莉,翟雪洁.乳腺癌转移、化疗抵抗与STC1的表达情况分析[J].临床与病理杂志,2016,36(10):1585-1588.